The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants—a multi-site prospective cohort study
Davidson, Aimee L, Dressel, Uwe, Norris, Sarah, Canson, Daffodil M, Glubb, Dylan M, Fortuno, Cristina, Hollway, Georgina E, Parsons, Michael T, Vidgen, Miranda E, Holmes, Oliver, Koufariotis, Lambros T, Lakis, Vanessa, Leonard, Conrad, Wood, Scott, Xu, Qinying, McCart Reed, Amy E, Pickett, Hilda A, Al-Shinnag, Mohammad K, Austin, Rachel L, Burke, Jo, Cops, Elisa J, Nichols, Cassandra B, Goodwin, Annabel, Harris, Marion T, Higgins, Megan J, Ip, Emilia L, Kiraly-Borri, Catherine, Lau, Chiyan, Mansour, Julia L, Millward, Michael W, Monnik, Melissa J, Pachter, Nicholas S, Ragunathan, Abiramy, Susman, Rachel D, Townshend, Sharron L, Trainer, Alison H, Troth, Simon L, Tucker, Katherine M, Wallis, Mathew J, Walsh, Maie, Williams, Rachel A, Winship, Ingrid M, Newell, Felicity, Tudini, Emma, Pearson, John V, Poplawski, Nicola K, Mar Fan, Helen G, James, Paul A, Spurdle, Amanda B, Waddell, Nicola, Ward, Robyn L
Published in Genome medicine (19.09.2023)
Published in Genome medicine (19.09.2023)
Get full text
Journal Article